FDA's Mary Ann Danello, PhD
Executive Summary
Staffer recently detailed to acting special asst. for biotechnology in commissioner's office. She has been special asst. for science since 1983. Henry Miller, MD, who has been medical officer in Biological Investigations Div., is on 180-day detail to assist Danello ("The Pink Sheet" July 15, In Brief). O Staffer recently detailed to acting special asst. for biotechnology in commissioner's office. She has been special asst. for science since 1983. Henry Miller, MD, who has been medical officer in Biological Investigations Div., is on 180-day detail to assist Danello ("The Pink Sheet" July 15, In Brief).
You may also be interested in...
Device Week, 05 March - Remote Monitoring Reimbursement, T-cell Diagnostics And A Digital Health Feature
In this week's podcast, managing editor Marion Webb discusses a new monthly digital health roundup which will soon feature on Medtech Insight. Managing editor Reed Miller discusses reimbursement difficulties as it applies to remote cardiac monitoring. UK-based reporter Barnaby Pickering gives an overview of an interview with the chief medical officer of Adaptive Biotechnologies about its new T-Detect platform.
Coronavirus Notebook: Italy Makes First Use Of EU’s Vaccine Export Control System, More Regulators Issue Guidance On Variants
Ukraine has established a system for issuing emergency use authorizations for COVID-19 vaccines that recognizes authorizations granted by other world regulators.
Pipeline Watch: Phase III Readouts In Alopecia Areata, Cervical Dysplasia, Anaphylaxis
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: